Hyundai Bioscience Co Ltd (048410) Stock Price & News

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	553.06M	-	324.68M	520.40M
Cost of goods sold	599.23M	-	401.27M	684.66M
Cost of revenue	599.23M	-	401.27M	684.66M
Research and development expenses	-	-	5.74B	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	4.57B	-	-1.32B	5.37B
Operating expense	4.57B	-	4.59B	5.37B
Total operating expenses	5.17B	-	4.99B	6.06B
Operating income	-4.62B	-	-4.66B	-5.54B
Other non operating income	96.21M	-	554.81M	-1.63B
EBT including unusual items	-7.00B	-	-5.31B	-7.58B
EBT excluding unusual items	-7.00B	-	-5.04B	-7.58B
Income tax expense	-41.50K	-	-	1.82B
Effective tax rate	-	-	-	-24.00%
Other operating expenses	-	-	13.53M	-
Net income	-7.00B	-	-5.31B	-11.56B
Net profit margin	-1,265.22%	-	-1,636.30%	-2,221.19%
Earnings per share	-	-	-	-
Interest and investment income	-	-	522.09M	-
Interest expense	-	-	-1.00B	-
Net interest expenses	-	-	-480.17M	-
Depreciation and amortization charges	-	-	286.20M	-
EBITDA	-4.27B	-	-4.32B	-5.16B
Gain or loss from assets sale	-	-	-	-

Finance